ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

CGOP Gets New Life, Will Move T DCT; DCPC May Fund More CCOPs with Money It Saves

July 25, 1986

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

RFAs Available

February 23, 1996

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

NCI Awards STRAP Grant Of $2 Million To MSKCC

October 22, 2010